Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine
Background<i>:</i> Vaccinia is known to induce antibody and cellular responses. Plasmablast, circulating follicular helper T (cT<sub>FH</sub>) cells, cytokine-expressing CD4 T cells, and memory B cells were compared between subcutaneous (SC) and needle-free jet injection (JI)...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/1/69 |
id |
doaj-b981b0a028ff4964854270d33aae4b51 |
---|---|
record_format |
Article |
spelling |
doaj-b981b0a028ff4964854270d33aae4b512020-11-25T02:06:05ZengMDPI AGVaccines2076-393X2020-02-01816910.3390/vaccines8010069vaccines8010069Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara VaccineEvan J. Anderson0Lilin Lai1Jens Wrammert2Sarah Kabbani3Yongxian Xu4Lalita Priyamvada5Heather Hill6Johannes B. Goll7Travis L. Jensen8Carol Kao9Inci Yildirim10Nadine Rouphael11Lisa Jackson12Mark J. Mulligan13.Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.Hope Clinic, Department of Medicine, Emory University School of Medicine, Decatur, GA 30030, USA.Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.Hope Clinic, Department of Medicine, Emory University School of Medicine, Decatur, GA 30030, USA.Hope Clinic, Department of Medicine, Emory University School of Medicine, Decatur, GA 30030, USA.Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.The Emmes Corporation, Rockville, MD 20850, USA.The Emmes Corporation, Rockville, MD 20850, USA.The Emmes Corporation, Rockville, MD 20850, USA.Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.Hope Clinic, Department of Medicine, Emory University School of Medicine, Decatur, GA 30030, USA.Kaiser Permanente, Seattle, WA 98101, USA.Hope Clinic, Department of Medicine, Emory University School of Medicine, Decatur, GA 30030, USABackground<i>:</i> Vaccinia is known to induce antibody and cellular responses. Plasmablast, circulating follicular helper T (cT<sub>FH</sub>) cells, cytokine-expressing CD4 T cells, and memory B cells were compared between subcutaneous (SC) and needle-free jet injection (JI) recipients of non-replicating modified vaccinia Ankara (MVA) vaccine. Methods<i>:</i> Vaccinia-naïve adults received MVA SC or by JI on Days 1 and 29. Vaccinia-specific antibodies were quantified by plaque reduction neutralization test (PRNT) and enzyme-linked immunosorbent assay. Plasmablast, cT<sub>FH</sub>, and cytokine-expressing CD4 T cells were assessed on Days 1, 8, 15, 29, 36, 43 (cT<sub>FH</sub> and CD4+ only) and 57. Memory B cells were measured on Days 1 and 57. Results<i>:</i> Of the 36 enrolled subjects, only 22 received both vaccinations and had evaluable specimens after the second vaccine. Plasmablasts peaked one week after each vaccine. Day 15 plasmablasts correlated with peak PRNT titers. cT<sub>FH</sub> peaked on Days 8 and 36 and correlated with Day 36 plasmablasts. CD4+ peaked at Day 29 and one-third produced ≥2 cytokines. Day 57 memory B cells ranged from 0.1% to 0.17% of IgG-secreting B cells. Conclusions<i>:</i> This study provides insights into the cellular responses to non-replicating MVA, currently used as a vector for a variety of novel vaccines.https://www.mdpi.com/2076-393X/8/1/69mvasmallpoxfollicular helper t cells (tfh), plasmablastsvacciniaantibody secreting cells |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Evan J. Anderson Lilin Lai Jens Wrammert Sarah Kabbani Yongxian Xu Lalita Priyamvada Heather Hill Johannes B. Goll Travis L. Jensen Carol Kao Inci Yildirim Nadine Rouphael Lisa Jackson Mark J. Mulligan |
spellingShingle |
Evan J. Anderson Lilin Lai Jens Wrammert Sarah Kabbani Yongxian Xu Lalita Priyamvada Heather Hill Johannes B. Goll Travis L. Jensen Carol Kao Inci Yildirim Nadine Rouphael Lisa Jackson Mark J. Mulligan Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine Vaccines mva smallpox follicular helper t cells (tfh), plasmablasts vaccinia antibody secreting cells |
author_facet |
Evan J. Anderson Lilin Lai Jens Wrammert Sarah Kabbani Yongxian Xu Lalita Priyamvada Heather Hill Johannes B. Goll Travis L. Jensen Carol Kao Inci Yildirim Nadine Rouphael Lisa Jackson Mark J. Mulligan |
author_sort |
Evan J. Anderson |
title |
Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine |
title_short |
Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine |
title_full |
Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine |
title_fullStr |
Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine |
title_full_unstemmed |
Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine |
title_sort |
plasmablast, memory b cell, cd4+ t cell, and circulating follicular helper t cell responses to a non-replicating modified vaccinia ankara vaccine |
publisher |
MDPI AG |
series |
Vaccines |
issn |
2076-393X |
publishDate |
2020-02-01 |
description |
Background<i>:</i> Vaccinia is known to induce antibody and cellular responses. Plasmablast, circulating follicular helper T (cT<sub>FH</sub>) cells, cytokine-expressing CD4 T cells, and memory B cells were compared between subcutaneous (SC) and needle-free jet injection (JI) recipients of non-replicating modified vaccinia Ankara (MVA) vaccine. Methods<i>:</i> Vaccinia-naïve adults received MVA SC or by JI on Days 1 and 29. Vaccinia-specific antibodies were quantified by plaque reduction neutralization test (PRNT) and enzyme-linked immunosorbent assay. Plasmablast, cT<sub>FH</sub>, and cytokine-expressing CD4 T cells were assessed on Days 1, 8, 15, 29, 36, 43 (cT<sub>FH</sub> and CD4+ only) and 57. Memory B cells were measured on Days 1 and 57. Results<i>:</i> Of the 36 enrolled subjects, only 22 received both vaccinations and had evaluable specimens after the second vaccine. Plasmablasts peaked one week after each vaccine. Day 15 plasmablasts correlated with peak PRNT titers. cT<sub>FH</sub> peaked on Days 8 and 36 and correlated with Day 36 plasmablasts. CD4+ peaked at Day 29 and one-third produced ≥2 cytokines. Day 57 memory B cells ranged from 0.1% to 0.17% of IgG-secreting B cells. Conclusions<i>:</i> This study provides insights into the cellular responses to non-replicating MVA, currently used as a vector for a variety of novel vaccines. |
topic |
mva smallpox follicular helper t cells (tfh), plasmablasts vaccinia antibody secreting cells |
url |
https://www.mdpi.com/2076-393X/8/1/69 |
work_keys_str_mv |
AT evanjanderson plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine AT lilinlai plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine AT jenswrammert plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine AT sarahkabbani plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine AT yongxianxu plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine AT lalitapriyamvada plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine AT heatherhill plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine AT johannesbgoll plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine AT travisljensen plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine AT carolkao plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine AT inciyildirim plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine AT nadinerouphael plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine AT lisajackson plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine AT markjmulligan plasmablastmemorybcellcd4tcellandcirculatingfollicularhelpertcellresponsestoanonreplicatingmodifiedvacciniaankaravaccine |
_version_ |
1724935114561945600 |